|
1 Company |
|
2 Products |
|
2 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
3 News |
|
- bortezomib / Generic mfg., everolimus / Generic mfg.
Trial termination, Trial primary completion date: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma (clinicaltrials.gov) - Oct 28, 2015
P1, N=30, Terminated, Sponsor: Brian Hill, MD, PhD
Recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Oct 2015; Treatment ineffective
- bortezomib / Generic mfg., everolimus / Generic mfg.
Trial primary completion date: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma (clinicaltrials.gov) - Jan 26, 2015
P1, N=36, Recruiting, Sponsor: Brian Hill, MD, PhD
Recruiting --> Terminated | Trial primary completion date: Jun 2015 --> Oct 2015; Treatment ineffective Trial primary completion date: Jan 2015 --> Jun 2015
- bortezomib / Generic mfg., everolimus / Generic mfg.
Trial primary completion date: Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma (clinicaltrials.gov) - Jul 23, 2014
P1, N=36, Recruiting, Sponsor: Brian Hill, MD, PhD
Trial primary completion date: Jan 2015 --> Jun 2015 Trial primary completion date: Nov 2013 --> Jan 2015